RBC Capital Markets reissued their underperform rating on shares of Stericycle Inc. (NASDAQ:SRCL) in a research note released on Monday. They currently have a $77.00 target price on the stock, down from their previous target price of $89.00.
Several other brokerages have also commented on SRCL. Zacks Investment Research upgraded shares of Stericycle from a hold rating to a buy rating and set a $119.00 price target on the stock in a research note on Thursday, July 21st. Royal Bank Of Canada dropped their price target on shares of Stericycle from $89.00 to $77.00 and set an underperform rating on the stock in a research note on Monday. Imperial Capital dropped their price target on shares of Stericycle from $100.00 to $95.00 and set an in-line rating on the stock in a research note on Thursday, May 26th. Finally, Jefferies Group restated a buy rating and issued a $125.00 price target on shares of Stericycle in a research note on Tuesday, August 23rd. Three investment analysts have rated the stock with a sell rating, ten have given a hold rating and three have given a buy rating to the stock. The stock currently has a consensus rating of Hold and a consensus target price of $110.32.
Stericycle (NASDAQ:SRCL) opened at 78.00 on Monday. Stericycle has a 12 month low of $77.00 and a 12 month high of $151.57. The company has a 50-day moving average price of $85.11 and a 200 day moving average price of $102.87. The firm has a market cap of $6.63 billion, a PE ratio of 27.46 and a beta of 0.27.
Stericycle (NASDAQ:SRCL) last released its quarterly earnings data on Thursday, July 28th. The company reported $1.18 earnings per share for the quarter, hitting the consensus estimate of $1.18. The firm had revenue of $891.60 million for the quarter, compared to analyst estimates of $910.29 million. Stericycle had a net margin of 7.22% and a return on equity of 14.84%. Stericycle’s quarterly revenue was up 24.6% on a year-over-year basis. During the same quarter in the prior year, the business earned $1.14 earnings per share. Equities research analysts anticipate that Stericycle will post $4.67 EPS for the current year.
In related news, Director Mark C. Miller sold 24,665 shares of the firm’s stock in a transaction that occurred on Friday, July 1st. The shares were sold at an average price of $104.55, for a total value of $2,578,725.75. Following the completion of the transaction, the director now owns 229,449 shares of the company’s stock, valued at approximately $23,988,892.95. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, EVP John P. Schetz sold 1,398 shares of the firm’s stock in a transaction that occurred on Wednesday, September 14th. The stock was sold at an average price of $81.85, for a total transaction of $114,426.30. Following the completion of the transaction, the executive vice president now directly owns 1,088 shares of the company’s stock, valued at approximately $89,052.80. The disclosure for this sale can be found here. 3.30% of the stock is currently owned by corporate insiders.
Institutional investors have recently bought and sold shares of the company. Torray LLC raised its position in Stericycle by 53.6% in the first quarter. Torray LLC now owns 420,707 shares of the company’s stock worth $53,089,000 after buying an additional 146,805 shares in the last quarter. Badgley Phelps & Bell Inc. raised its position in Stericycle by 5.6% in the first quarter. Badgley Phelps & Bell Inc. now owns 59,172 shares of the company’s stock worth $7,467,000 after buying an additional 3,144 shares in the last quarter. Dynamic Advisors Solutions LLC raised its position in Stericycle by 1.7% in the first quarter. Dynamic Advisors Solutions LLC now owns 5,122 shares of the company’s stock worth $646,000 after buying an additional 85 shares in the last quarter. Virginia Retirement System purchased a new position in Stericycle during the first quarter worth approximately $2,572,000. Finally, Nisa Investment Advisors L.L.C. raised its position in Stericycle by 1.1% in the first quarter. Nisa Investment Advisors L.L.C. now owns 27,948 shares of the company’s stock worth $3,527,000 after buying an additional 300 shares in the last quarter. 92.81% of the stock is owned by hedge funds and other institutional investors.
Stericycle Company Profile
Stericycle, Inc is a business-to-business services provider with a focus on regulated and compliance solutions for healthcare, retail and commercial businesses. The Company’s solutions include the collection and processing of specialized waste for disposal, the collection of personal and confidential information for secure destruction, and a range of training, consulting, recall/return, communication and compliance services.
Receive News & Ratings for Stericycle Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stericycle Inc. and related companies with MarketBeat.com's FREE daily email newsletter.